Protein Tyrosine Kinases (PTK) in Multiple Myeloma

计划入组 10 人 · 首次发布于 2005 年 9 月 14 日

Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis

计划入组 896 人 · 首次发布于 2025 年 6 月 15 日

Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases

计划入组 154 人 · 首次发布于 2010 年 11 月 25 日

cdc2-like kinases/Dyrk1A inhibitors (NCATS)

TrkB receptor-agonizing mAbs (Wyeth)

Recombinanthuman Type III Collagen(kexing)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Carlos Iii Health Institute

Spain

Inhibikase Therapeutics Advances IKT-001 to Global Phase 3 Study for Pulmonary Arterial Hypertension

Inhibikase Therapeutics Initiates Phase 3 IMPROVE-PAH Trial for Novel Pulmonary Arterial Hypertension Treatment

EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds